Tokyo, Japan

Kamon Shirakawa

USPTO Granted Patents = 24 

 

 

Average Co-Inventor Count = 1.9

ph-index = 6

Forward Citations = 129(Granted Patents)


Location History:

  • Saitama, JP (1997 - 1998)
  • Shinjuku-ku, JP (2006)
  • Shizuoka, JP (2008 - 2012)
  • Yokohama, JP (2021)
  • Tokyo, JP (2000 - 2023)

Company Filing History:


Years Active: 1997-2023

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: **Kamon Shirakawa: A Pioneer in Sepsis Detection**

Introduction

Kamon Shirakawa, based in Tokyo, Japan, is a renowned inventor whose innovations have significantly contributed to the field of medical diagnostics, particularly in the detection of sepsis. With an impressive portfolio of 24 patents, Shirakawa has established himself as a key figure in the scientific community.

Latest Patents

Shirakawa's latest inventions include groundbreaking methods and compositions for determining sepsis in individuals. One notable patent is for an anti-presepsin antibody, which provides a means to identify sepsis by using antibodies that specifically bind to the biomarker presepsin. This invention facilitates the development of monoclonal antibodies that target specific epitopes of presepsin, offering an advanced approach to sepsis detection. Another significant patent features specifically purified anti-presepsin polyclonal antibodies, designed to minimize variability in measurements between different batches compared to earlier antibody variants. These advancements are critical for the accurate assessment and treatment of sepsis.

Career Highlights

Throughout his career, Kamon Shirakawa has worked with prominent organizations including Mochida Pharmaceutical Co., Ltd. and Osaka Bioscience Institute. His efforts in research and development have led to notable scientific achievements and have earned him respect among his peers in the biomedical field.

Collaborations

In his professional journey, Shirakawa has collaborated with fellow researchers such as Shoji Furusako and Tomokazu Matsusue. These partnerships have been instrumental in advancing his work and fostering innovation in medical diagnostics.

Conclusion

Kamon Shirakawa's contributions to the detection of sepsis through his patented inventions highlight the significant impact of innovative research in healthcare. His dedication to improving diagnostic methods for sepsis has not only advanced scientific understanding but also enhanced patient care, showcasing the importance of inventions in addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…